Mitsubishi Chemical Holdings Corp reported a significant earnings miss for Q4 2025, with an EPS of -68.07 JPY against a forecast of 10.65 JPY, a surprise of -739.15%. Despite this, the company’s stock rose by 13.54%, closing at 1054 JPY.
The market’s positive reaction was likely driven by revenue surpassing expectations and strategic cost-cutting measures. According to Bond.az data, the company remains unprofitable over the last twelve months but maintains a strong free cash flow yield of 14%.
Mitsubishi Chemical’s overall performance in FY 2025 was mixed. While sales revenue and core operating income declined, strategic cost-cutting and a strong Industrial Gases segment helped mitigate losses.
Looking ahead, the company projects an EPS of 0.37 USD for FY2027 Q2, with a gradual recovery expected in the MMA monomer market. With a price-to-book ratio of 0.66, the stock may appeal to value-focused investors.
